Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for KAPSELFORMULIERUNGEN
Details for 2023160271
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2023160271
Title / Product Name
KAPSELFORMULIERUNGEN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2023160271
EP Publication Number
4233850
E-Number
1727975
Language
EN
PCT Number
Publication Date
30.08.2023 A
02.10.2024 B1
Registration Date
02.10.2024
AT Publication Date
15.10.2024
Application Date
27.11.2019
Registration Number
-
Priorities
30.11.2018
US
201862773848 P
IPC
A61K 9/48 20060101AFI20230816BHEP
Maximum Duration of Protection
27.11.2039
Owner
ChemoCentryx, Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320
US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OG
Biberstraße 22
1010 Wien
AT
Inventor
LELETI, Manmohan Reddy
California, 94568
US
POWERS, Jay P
California, 94044
US
Information about Fees
Click here to load the fees